Anti-inflammatory effects of lipoxins on lipopolysaccharide-induced uveitis in rats

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 6, 2009, Pages 483-486

  Karim, Md Jahurul ^a   Bhattacherjee, Parimal ^a   Biswas, Sumana ^a   Paterson, Christopher A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; KETAMINE; LIPOPOLYSACCHARIDE; LIPOXIN A; LIQUID NITROGEN; MYELOPEROXIDASE; PROTEIN; XYLAZINE;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DISSECTION; DRUG EFFECT; ENUCLEATION; ENZYME ASSAY; LENS; LEUKOCYTE COUNT; MALE; NEUTROPHIL COUNT; NONHUMAN; POLYMORPHONUCLEAR CELL; RAT; TISSUE SECTION; UVEITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AQUEOUS HUMOR; LIPOPOLYSACCHARIDES; LIPOXINS; MALE; NEUTROPHIL INFILTRATION; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; UVEITIS;

EID: 77149156927     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0134     Document Type: Article

References (32)

1. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biol. 231:232-235, 1971.
2. Samuelsson, B., Dahlen, S.E., Lindgren, J.A., et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1171-1176, 1987.
3. Coleman, R.A., Smith, W.L., and Narumiya, S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol. Rev. 46:205-229, 1994.
4. Dinarello, C.A., and Mier, J.W. Interleukins. Annu. Rev. Med. 37:173-178, 1986.
5. Dinarello, C.A., and Mier, J.W. Lymphokines. N. Engl. J. Med. 317:940-945, 1987.
6. Cotran, R.S., and Pober, J.S. Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J. Am. Soc. Nephrol. 1:225-235, 1990.
7. Dinarello, C.A. Cytokines and biocompatibility. Blood Purif. 8:208-213, 1990.
8. Serhan, C.N., Brain, S.D., Buckley, C.D., et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21:325-332, 2007.
9. Serhan, C.N., and Chiang, N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 153:S200-S215, 2008.
10. Serhan, C.N., Hamberg, M., and Samuelsson, B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl. Acad. Sci. USA. 81:5335-5339, 1984. (Pubitemid 14048742)
11. Serhan, C.N., Hamberg, M., and Samuelsson, B. Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes. Biochem. Biophys. Res. Commun. 118:943-949, 1984. (Pubitemid 14194804)
12. Serhan, C.N. Lipoxin and aspirin-triggered 15-epilipoxins are the fi rst lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot. Essent. Fatty Acids. 73:141-162, 2005.
13. Serhan, C.N., Takano, T., and Maddox, J.F. Aspirin-triggered 15-epi-lipoxin A4 and stable analogs on lipoxin A4 are potent inhibitors of acute inflammation. Receptors and pathways. Adv. Exp. Med. Biol. 447:133-149, 1999.
14. Fierro, I.M., and Serhan, C.N. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. Braz. J. Med. Biol. Res. 34:555-566, 2001.
15. Serhan, C.N., and Chiang, N. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirintriggered 15-epi-lipoxins. Scientific World J. 2:169-204, 2002.
16. Serhan, C.N., Fiore, S., Damian, A., et al. Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. Biochemistry. 32:6313-6319, 1993.
17. Clish, C.B., Levy, B.D., Chiang, N., et al. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J. Biol. Chem. 275:25372-25380, 2000. (Pubitemid 30687036)
18. Serhan, C.N., Maddox, J.F., Petasis, N.A., et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry. 34:14609-14615, 1995.
19. Takano, T., Fiore, S., Maddox, J.F., et al. Aspirin-triggered 15-epilipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185:1693-1704, 1997.
20. Lowry, O.H., Rosebrough, N.J., Farr, A.L., et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275, 1951.
21. Schultz, J., and Kaminker, K. Myeloperoxidase of the leukocyte of normal human blood. I. Content and localization. Arch Biochem. Biophys. 96:465-467, 1962.
22. Williams, R.N., Paterson, C.A., Eakins, K.E., et al. Quantification of ocular inflammation: evaluation of polymorphonuclear leucocyte infiltration by measuring myeloperoxidase activity. Curr. Eye Res. 2:465-470, 1982-1983.
23. Graff, G., Gamache, D.A., Brady, M.T., et al. Improved myeloperoxidase assay for quantification on neutrophil influx in a rat model of endotoxin-induceduveitis. J. Pharmacol. Toxicol. Methods. 39:169-178, 1998.
24. Cotran, R.S., Kumar, V., and Collins, T. Robbins Pathologic Basis of Disease. Philadelphia: WB Saunders; 1999.
25. Serhan, C.N., Yacoubian, S., and Yang, R. Anti-inflammatory and pro-resolving lipid mediators. Annu. Rev. Pathol. 3:279-312, 2008.
26. Gilroy, D.W., Lawrence, T., Perretti, M., et al. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3:401-416, 2004.
27. Serhan, C.N. Resolution phase of inflammation: novel endogenous anti-inflammatory and pro-resolving lipid mediators and pathways. Annu. Rev. Immunol. 25:101-137, 2007.
28. Gronert, K., Maheshwari, N., Khan, N., et al. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280:15267-15278, 2005.
29. Jin, Y., et al. Association for research in vision and ophthalmology. Invest. Ophthalmol. Vis. Sci. 48:E-Abstract 199, 2007.
30. Connor, K.M., SanGiovanni, J.P., Lofqvist, C., et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13:868-873, 2007.
31. Baatz, H., Pleyer, U., Thiel, H.J., et al. In vivo study of leukocyteendothelium interaction in endotoxin-induceduveitis. Invest. Ophthalmol. Vis. Sci. 36:1960-1967, 1995.
32. Medeiros, R., Rodrigues, G.B., Figueiredo, C.P., et al. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induceduveitis. Mol. Pharmacol. 74:154-161, 2008.